Clarification on Meningitis RecallThursday, October 11, 2012
Last week, the Centers for Disease Control (CDC) reported that specific products from the New England Compounding Center (NECC) were contaminated. Practices that have received Methylprednisolone Acetate from NECC were asked to contact patients who received this medication after May 21, 2012, and educate them on the adverse effects. Any cases should be reported here.
Other practices that received shipments from NECC (logo available here) are asked to temporarily stop dispensing these products and report any adverse reactions from patients who received medication from NECC. More information is available here.
Want to continue the discussion on the OSMA Community? Click here to post your thoughts and connect with your peers on the OSMA’s member-only forum.